Article
Not All Predictors Of RCC Clusters Are The Same: An individual sample predictive model to classify patients with metastatic renal cell carcinoma
2026-06-29
Abstract excerpt
Clear cell renal cell carcinoma (RCC) patients have multiple approved therapies, including anti-angiogenesis tyrosine kinase inhibitors (TKIs) and immuno-oncology therapies (IO), but lack a clinically validated biomarker. Using RNAseq data from the IMmotion 151 clinical trial (IM151) 1–3 , 7 RCC biologic clusters have been defined 3 . Several groups have attempted to predict these clusters on various RCC dataset...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 538f6b8e-5f3b-50ab-b942-5412a40f49ad
- DOI
- 10.64898/2026.06.24.734285
